EVENTS

Human Cell Atlas (HCA) Asia Meeting 2019

Venue: Biopolis, Singapore

1^st Annual Human Genomics Symposium 2019

Venue: National University of Singapore, Singapore

National University Health System (NUHS), Genome Institute of Singapore (GIS) and NovogeneAIT Genomics Singapore will be jointly hosting the 1st Annual Human Genomics Symposium. The theme of the symposium is “Advancing Genomics Research”. This symposium will focus on emerging, or next generation research areas in the field of human genomics and technologies for research and diagnostics. This symposium aims to provide a platform for clinicians and scientists to present their work, exchange ideas and learn about the latest advancements in this rapidly evolving field. We expect around 200 scientists and clinicians who are working in the field of human genomics to participate in the symposium. The symposium topics have been selected to capture a snapshot of the state of the art in these rapidly evolving research areas. The topics include Cancer, Population Genomics, and Chronic Diseases.

c-BIG Symposium 2019

Biopolis, Singapore

Cell Symposium 2019 - Single Cell: Technology to Biology

Biopolis, Singapore

Sing-a-Pore Camp 2018

Biopolis, Singapore

Stem Cell Society Singapore Symposium 2017

Academia, Singapore General Hospital

Joint Singapore-EMBL Symposium on Precision Medicine 2017

13th November (public), Breakthrough and Discovery theatrettes, Biopolis, Singapore
14th November (closed-door), Genome Institute of Singapore, Biopolis, Singapore

Frontiers in Cancer Science 2017

Venue: Matrix, Biopolis, Singapore

Launch of GIS-IVQ Joint Innovation Laboratory for Precision Oncology

Venue: Tudor Ballroom, Goodwood Park Hotel

GIS-NCIS Faculty Exchange Programme MOU Signing Ceremony

Venue: National Cancer Centre, Singapore

Atreca-GIS Joint Lab for Immuno-Oncology Opening Ceremony

Venue: Genome, Biopolis, Singapore

c-BIG Symposium 2016

Venue: Matrix, Biopolis, Singapore

SCSS Symposium 2016

Venue: Matrix, Biopolis, Singapore

PerkinElmer-GIS Centre for Precision Oncology Opening Ceremony

Venue: Genome, Biopolis, Singapore

GIS 15th Anniversary Gala Dinner

Venue: Shangri-La Hotel, Tower Ballroom, Singapore 258350

ICSB 2015

Venue: Biopolis, Singapore

Stem Cell Society Singapore Symposium 2015 "Opportunities & Challenges in Stem Cell Based Medicine"

Venue: Biopolis, Singapore

Cell Symposium: Human Genomics

Venue: Matrix, Biopolis, Singapore

6th Next-Generation Sequencing Conference

Venue: Biopolis, Matrix
Breakthrough/ Discovery Theatre

Functions of Non-Coding RNAs in Evolution, Epigenetics and Therapeutic Applications

Venue: Genome Institute of Singapore

Regional Forum Series 2014: Global Controls in Stem Cells

Venue: Matrix, Biopolis, Singapore

Epigenetics in Development and Diseases: 9th Asian Epigenomics Meeting

Venue: Matrix, Biopolis, Singapore

Stem cells for modeling development and disease

Venue: Matrix, Biopolis, Singapore

BD BIOSCIENCES and GIS collaborate on 'Isolation and characterization of human tissue samples using Flow Cytometry and RNAFlow Technology'

For more info, click here

SCSS SYMPOSIUM 2012

Stem Cell Based Therapy

Partner of 5th Annual BioPharma Asia Convention 2012

Human Genome Meeting 2012

Genetics and Genomics in Personalized Medicine Sydney, Australia

Though the practice of medicine has always sought to "personalise" the care and treatment of patients, the genetics-to-genomics revolution has taken this to the next level with comprehensive, precise, and quantitative genomic technologies. Next generation DNA sequencing, SNP arrays, novel amplification technologies, and microfluidic devices with the accompanying computational advances now speed discovery and the resolution of diagnosis by orders of magnitude. The promise of precise diagnosis, of accurate patient stratification for risk assessment and treatment, and sensitive monitoring is likely to be fulfilled in the next decade. Underpinning all this are the advances in computational biology and eHealth that are necessary to deal with the impending information overload. HGM 2012 will explore the fundamental, translational, and clinical sciences driving the progress of this personalised medicine movement. With the Royal College of Pathologists of Australasia, we will also host a special session on Genomic Pathology to highlight the importance of this discipline to personalised genomic-based medicine.

3rd Annual RNAi Asia, 22 - 23 Nov 2011

Frontiers in Cancer Science 2011, 31 Oct - 3 Nov 2011

Click here for the poster

ChIA-PET Analysis Workshop: Methods for a Chromatin Interaction Analysis

Venue: Genome, Biopolis, Singapore

Personalized Cancer Medicine 2011: Towards individualized cancer treatments

Venue: Matrix, Biopolis, Singapore

RNAi Asia/Screening Asia

Venue: Matrix, Biopolis, Singapore

Stem Cell Society Singapore Symposium 2010 Translating Science to Therapy

Venue: Matrix, Biopolis, Singapore

27th HUGO-IABCR Congress 2010

Venue: Biopolis, Singapore

National Science Challenge

Venue: Genome, Biopolis, Singapore

GIS-AH MOU Signing Ceremony

Venue: Khoo Teck Puat Hospital, Singapore

Seminars by GIS Distinguished Speaker, Dr. Kevin Struhl

Venue: Matrix, Biopolis, Singapore

Epigenetics in Development and Diseases Conference: 4th Asian Epigenomics Meeting

Venue: Biopolis, Singapore

Statistical Genomics Program

Venue: Singapore

FRET, FLIM, FCS, FRAP and 3-D Imaging : Application to Cell and Developmental Biology

Venue: Biopolis, Singapore

Genetics and Genomics of Infectious Diseases Conference

Venue: The Ritz Carlton Millenia Hotel, Singapore

Regulatory networks in Stems Cells Conference

Venue: Pan Pacific, Singapore

Chromatin conference: Histones, Nucleosomes, Chromosomes and Genomes

Venue: Pan Pacific, Singapore

A*STAR-Karolinska-Dundee Research Symposium

Venue: The Biopolis, Matrix, Singapore

Human Genome Organisation (HUGO) 13th Human Genome Meeting

Venue: Hyderabad, India

Asia-Pacific Regional S.pombe Meeting 2008, Singapore 25 - 27 July 2008

Venue: Biopolis and Temasek Life Sciences Laboratory (TLL)

Joint 7th Human Genome Organisation (HUGO) - Pacific Meeting and the 8th Asia-Pacific Conference on Human Genetics

Venue: Cebu, Philippines

AACR Centennial Conference

AACR Centennial Conference November 4 - 8, 2007 Suntec Singapore

GIS Invited Speakers Series 2007

Invited Speaker: Prof. Jack D. Keene Duke University Medical Center, Molecular Genetics & Microbiology, James B. Duke Professor) Hosted by: Dr. Andrew Thomson Seminar Date: To be confirmed Title of seminar: Coordination of Genetic Information by Post-transcriptional RNA Operons Venue: To be confirmed

Genome Institute of Singapore Open House

Explore opportunities for graduate study within a fast-paced and exciting genomics research institute
Date: 16th May 2006, Tuesday Time: 9.30am to 2.00pm
Programme for the day

Genetic variation and Individul landscape of gene expression

Guest Speaker: Professor Peter Little School of Biotechnology & Biomolecular Sciences, University of New South Wales, Sydney, Australia Date: 23 March 2006, Thursday Time: 4:00 - 5:00 pm Venue: Aspiration Theatrette - Level 2M, Matrix Building, Biopolis Host: Dr Larry Stanton Abstract: We wish to understand how genetic variation influences the tissue specific control of gene expression in mice. We use microarrays and networks to analyse and display genetic correlations and linkage, and to describe the landscape of genetic influence within and between tissues of individuals. These show that genetic variation can cause a gene's mRNA level to vary between individuals by an average factor of ~12. These large influences alter tissue specificity of gene expression and in many cases affect regulons (groups of co-ordinately influenced genes) and this further increases inter-tissue differences. The fact that individuals have very different tissue landscapes of gene expression highlights the potential role of this type of genetic variation in the evolution of morphology. We believe there is very limited prospect of using model tissues to predict outcome in target tissues; this has substantial implications for the design of human studies, where access to phenotypically relevant tissues is necessarily limited.

All are welcome

Seminar: How the Epigenome Changes in Cancer

Guest Speaker: Prof. Peter A. Jones Distinguished Professor, Urology, Biochemistry & Molecular Biology University of Southern California, Keck School of Medicine, Los Angeles, CA President, American Association for Cancer Research Date: 15th February 2006, Wednesday Time: 9:00am – 10:00am Venue: Aspiration Theatrette, Level 2M Matrix Building, Biopolis Host: Prof. Edison Liu Abstract: The covalent modification of DNA cytosine residues and associated histone proteins play a major role in the stability and heritability of epigenetic states. These covalent modifications of DNA and proteins interact with the chromatin remodeling apparatus to regulate the interaction of transcription factors with DNA thus contributing to stable patterns of gene expression. CpG islands are usually unmethylated in normal tissues except for genes located on the inactive X-chromosome, imprinted genes and some tissue specific genes. Histones are marked by covalent modifications and we have found that active marks are highly localized to the start sites of human genes. These patterns of modification are altered during the formation of human cancer so that CpG islands become abnormally methylated, histones become modified with repressive marks and we have recently discovered that nucleosomal remodeling occurs, resulting in the silencing of genes. Focal changes such as these often occur in the presence of genomic cytosine hypomethylation and histone hyperacetylation showing a major imbalance in epigenetic programming. Epigenetic silencing can serve as a therapeutic target for epigenetic therapies which seek to reverse silencing and restore more normal gene expression patterns to cancer cells. To date, the focus has mainly been on the reactivation of protein coding genes yet we have found that micro RNAs can also become abnormally silenced in human cancer cells by such chromatin modifications. Reactivating micro RNAs could potentially yield a novel therapeutic strategy in the treatment of cancer.